Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
The FDA has approved certain medications (Victoza, Ozempic, Trulicity) for cardiovascular risk reduction in patients with established cardiovascular disease and type 2 diabetes, and Wegovy for cardiovascular risk reduction in adults with established cardiovascular disease who have overweight or obesity
It can have positive effects on your health and appearance, including brighter skin and a more balanced immune system
Folate transport across the blood-brain barrier is compromised in CFD and has been linked either to the presence of autoantibodies blocking the folate receptor-alpha (FR) or to mutations in the FOLR1 gene encoding FR (190-193)
Discuss insurance prior authorization requirements and potential manufacturer assistance programs
Since GLP-1 medications can result in weight loss, balanced blood sugar and lowered blood pressure, there has been a huge increase in recent years in the number of people taking them
